Analyzing Aveanna Healthcare (AVAH) & Its Competitors

Aveanna Healthcare (NASDAQ:AVAHGet Free Report) is one of 26 public companies in the “MED – OUTP/HM CRE” industry, but how does it contrast to its rivals? We will compare Aveanna Healthcare to similar businesses based on the strength of its institutional ownership, dividends, earnings, risk, valuation, analyst recommendations and profitability.

Risk & Volatility

Aveanna Healthcare has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Comparatively, Aveanna Healthcare’s rivals have a beta of 1.18, suggesting that their average stock price is 18% more volatile than the S&P 500.

Valuation & Earnings

This table compares Aveanna Healthcare and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Aveanna Healthcare $2.09 billion -$10.93 million 248.50
Aveanna Healthcare Competitors $3.79 billion $179.91 million 21.26

Aveanna Healthcare’s rivals have higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Aveanna Healthcare and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Aveanna Healthcare 0.26% -15.16% 1.14%
Aveanna Healthcare Competitors -12.27% -0.50% -4.12%

Insider & Institutional Ownership

88.0% of Aveanna Healthcare shares are owned by institutional investors. Comparatively, 71.8% of shares of all “MED – OUTP/HM CRE” companies are owned by institutional investors. 7.0% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 9.4% of shares of all “MED – OUTP/HM CRE” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Aveanna Healthcare and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare 1 2 1 0 2.00
Aveanna Healthcare Competitors 107 900 1355 57 2.56

Aveanna Healthcare currently has a consensus price target of $5.13, suggesting a potential upside of 3.12%. As a group, “MED – OUTP/HM CRE” companies have a potential upside of 22.85%. Given Aveanna Healthcare’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Aveanna Healthcare has less favorable growth aspects than its rivals.

Summary

Aveanna Healthcare rivals beat Aveanna Healthcare on 8 of the 13 factors compared.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.